TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

83%


Total
Publications

173


Total Open
Publications

143


Total
Citations

3.8K


Open Access
Percentage

83%


Total
Publications

173


Total Open
Publications

143


Total
Citations

3.8K

Wikipedia

Website

download

Breakdown

40% 37% 6% 17%

Publisher Open

40%

Both

37%

Other Platform Open

6%

Closed

17%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

55

Hybrid 25%

33

No Guarantees 33%

44

Other Platform Open

Domain 59%

44

Institution 38%

28

Other Internet 28%

21

Public 20%

15

Preprint 9%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
43
Europe PMC
Domain
31
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
15
Semantic Scholar
Public
12
Unknown Repository
Other Internet
4
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
4
AECID Library - Americanae
Institution
4
Research Square
Preprint
3
Zenodo
Public
2
University of Malta - OAR@UM
Institution
2
1 / 4

Data updated 13 August 2024

Share

Share

Share